Anton Orlin

Anton Orlin

Ophthalmology

840 Walnut Street
Floor 10
Philadelphia, PA 19107

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Pilot Clinical Trial of Topical Netarsudil to Lower Risk of Proliferative Vitreoretinopathy in High-Risk Primary Retinal Detachment.

Pilot Clinical Trial of Topical Netarsudil to Lower Risk of Proliferative Vitreoretinopathy in High-Risk Primary Retinal Detachment.

Journal: Journal of vitreoretinal diseases

Published: August 08, 2026

Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan.

Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan.

Journal: Journal of vitreoretinal diseases

Published: November 17, 2025

Erratum to "Disparities Between Clinical Trial Recruitment and Real-World Demographics in Macular Edema Secondary to Retinal Vein Occlusion," Am J Ophthalmol 2025; 269:429-434.

Erratum to "Disparities Between Clinical Trial Recruitment and Real-World Demographics in Macular Edema Secondary to Retinal Vein Occlusion," Am J Ophthalmol 2025; 269:429-434.

Journal: American journal of ophthalmology

Published: May 02, 2025

Incidence, Management, and Outcomes of Eyes with Comorbid Active Uveitis and Central Serous Chorioretinopathy.

Incidence, Management, and Outcomes of Eyes with Comorbid Active Uveitis and Central Serous Chorioretinopathy.

Journal: Retina (Philadelphia, Pa.)

Published: April 04, 2025

MULTIMODAL IMAGING IN DEFEROXAMINE-RELATED OCULAR TOXICITY: RAPID DEVELOPMENT DUE TO SUPRATHERAPEUTIC DOSING AND PROGRESSION DESPITE DOSE REDUCTION.

MULTIMODAL IMAGING IN DEFEROXAMINE-RELATED OCULAR TOXICITY: RAPID DEVELOPMENT DUE TO SUPRATHERAPEUTIC DOSING AND PROGRESSION DESPITE DOSE REDUCTION.

Journal: Retinal cases & brief reports

Published: March 11, 2025

Adverse Events Associated With 3 Vitrectomy Platforms Reported to the US FDA MAUDE Database.

Adverse Events Associated With 3 Vitrectomy Platforms Reported to the US FDA MAUDE Database.

Journal: Journal of vitreoretinal diseases

Published: September 25, 2024

Superotemporal predisposition to traumatic subretinal fibrosis in Stargardt disease: A case report.

Superotemporal predisposition to traumatic subretinal fibrosis in Stargardt disease: A case report.

Journal: American journal of ophthalmology case reports

Published: August 06, 2024

Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices.

Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices.

Journal: JAMA ophthalmology

Published: June 27, 2024

Google Search Trends to Assess Public Interest and Concern About Pegcetacoplan for the Treatment of Geographic Atrophy.

Google Search Trends to Assess Public Interest and Concern About Pegcetacoplan for the Treatment of Geographic Atrophy.

Journal: Ophthalmic surgery, lasers & imaging retina

Published: May 16, 2024

Disparities Between Clinical Trial Recruitment and Real-World Demographics in Macular Edema Secondary to Retinal Vein Occlusion.

Disparities Between Clinical Trial Recruitment and Real-World Demographics in Macular Edema Secondary to Retinal Vein Occlusion.

Journal: American journal of ophthalmology

Published: May 01, 2024

Prevalence and spectrum of manifestations of tamoxifen retinopathy as assessed by multimodal and ultra-widefield retinal imaging.

Prevalence and spectrum of manifestations of tamoxifen retinopathy as assessed by multimodal and ultra-widefield retinal imaging.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: March 06, 2024

Implementation of a Teleophthalmology Screening Program for Diabetic Retinopathy in New York City.

Implementation of a Teleophthalmology Screening Program for Diabetic Retinopathy in New York City.

Journal: Journal of vitreoretinal diseases

Published: January 15, 2024

Showing 1-12 of 58

Last Updated: 09/26/2026